Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment
Amanda Mocroft(University of Copenhagen), Lars Peters(University of Copenhagen), Sanjay Bhagani, Richard Haubrich(University of California San Diego), Johannes R. Bogner(Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation), Galina Kyselyova(Republican Oncological Clinical Dispensary), Gilles Wandeler(University of Bern), Inka Aho(Helsinki University Hospital), Fernando Maltêz(Hospital Curry Cabral), C Mussini(Azienda Ospedaliero-Universitaria di Modena), Jürgen K. Rockstroh(University of Bonn), Line Dahlerup Rasmussen(Odense University Hospital), Christian Pradier(Université Côte d'Azur), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Djordje Jevtović, Е. А. Бородулина(Samara State Medical University), T. N. Trofimova(Yaroslav-the-Wise Novgorod State University), Jan Gerstoft, Kerstin Kase(East Tallinn Central Hospital), Karolin Falconer(Karolinska University Hospital), Montse Laguno(Universitat de Barcelona), Elżbieta Bąkowska(Wojewódzki Szpital Zespolony)
Cited by 17
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k